TITLE

MED-TECH NEWS AND NOTES

PUB. DATE
September 2008
SOURCE
Medical Device Daily;9/17/2008, Vol. 12 Issue 199, p5
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This section offers news briefs related to medical technology in the U.S. Cyberonics reported that, based on an initial assessment, its corporate headquarters in Houston, Texas did not suffer any damage as a result of Hurricane Ike. CSMG Technologies, a technology management company, announced that it is moving its home office in Santa Barbara, California. Applied NeuroSolutions, a company specializing in products for the early diagnosis and treatment of Alzheimer's disease, hired William Blair & Co. to explore alternatives to enhance shareholder value.
ACCESSION #
34417053

 

Related Articles

  • PRODUCT BRIEFS.  // Medical Device Daily;1/8/2009, Vol. 13 Issue 4, p11 

    This section presents an update on issues related to medical devices and instruments in the U.S. Cyberonics filed a proposal to the Food and Drug Administration (FDA) to amend the protocol of its post-market dosing study in depressed patients undergoing VNS Therapy. FDA granted a second...

  • Critical moment for Wm. Blair. Strahler, Steven R. // Crain's Chicago Business;04/06/98, Vol. 21 Issue 14, p1 

    Presents information on William Blair & Company, an investment banking firm and how they performed during 1997. Reference to the decline in initial public offerings (IPO); Details on the hiring of accountant Arthur Andersen by Blair; Comments from Blair's chief executive officer, E. David Coolidge.

  • Blair fund caught in price updraft. Fritz, Michael // Crain's Chicago Business;9/25/95, Vol. 18 Issue 39, p12 

    Reports on the private equity fund of William Blair & Co. Reading of the financial markets; Comparison with the company's past efforts; Inside investors.

  • Cyberonics makes $4M investment in ImThera.  // Medical Device Daily;10/7/2011, Vol. 15 Issue 192, p2 

    The article reports on financing agreements in the U.S. medical device industry. Cyberonics has made an initial investment amounting to 4 million dollars in ImThera Medical, as part of an expected 12 million dollar total investment pending regulatory and clinical milestones. Kareo reports that...

  • Product Briefs.  // Medical Device Daily;10/25/2011, Vol. 15 Issue 204, p8 

    This section offers news briefs on the U.S. medical device sector. A 510(k) clearance was granted by the Food and Drug Administration (FDA) to Abbott for a new in vitro diagnostic test aimed at patients with acute myeloid leukemia. Applications were submitted by Cyberonics to both the FDA and...

  • Financings Roundup.  // BioWorld Today;10/3/2007, Vol. 18 Issue 192, p7 

    The article reports that Vernon Hills, Illinois-based Applied NeuroSolutions Inc. has completed a $2.9 million private placement of its common stock and warrants. About 20.7 million shares of unregistered common stock at 14 cents per share had been sold by the company to SF Capital Partners Ltd....

  • Agreements/contracts.  // Medical Device Daily;12/9/2009, Vol. 13 Issue 236, p3 

    This article focuses on the agreement reached between Applied NeuroSolutions and Eli Lilly for a one-year renewal of their drug discovery collaboration. Applied NeuroSolutions will receive 250,000 U.S. dollars as payment for the collaboration renewal. Particular focus is given to the terms of...

  • Applied NeuroSolutions renews collaboration with Lilly.  // PharmaWatch: CNS;Jan2010, Vol. 9 Issue 1, p5 

    The article reports that Applied NeuroSolutions Inc. has reported that Eli Lilly & Co. has agreed to a one-year renewal of its Alzheimer's disease drug discovery collaboration. Lilly will pay 250,000 dollars to Applied NeuroSolutions for the one-year collaboration renewal. Craig Taylor,...

  • Applied NeuroSolutions reports positive results from Alzheimer's test study.  // PharmaWatch: CNS;Sep2009, Vol. 8 Issue 9, p11 

    The article presents the results from Alzheimer's test study of Applied NeuroSolutions Inc. regarding the diagnosis of patients with Alzheimer's disease (AD). The results of the study show the ability of tau-based test to distinguish among patients with the disease and normal controls with a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics